News
- Bristol spin-out Dynamic Therapeutics wins prestigious Blavatnik Prize for U-RHYTHM technology 25 April 2024 Dynamic Therapeutics, a University of Bristol spin-out, has today [25 April] been awarded a prestigious Blavatnik Prize by QantX, a leading venture capital firm, for its pioneering U-RHYTHM technology. The award recognises the scientific advances and future potential of the UK's most innovative scientists and engineers.
- Students tackle gap in black and brown skin cancer diagnosis 11 April 2024 Three medical students are solving the shocking disparity in skin cancer care between those with dark skin and those with white skin.
- Screening with a PSA test has a small impact on prostate cancer deaths but leads to overdiagnosis 6 April 2024 The largest study to date investigating a single invitation to a PSA blood test to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and missed early detection of some aggressive cancers. The CAP trial, published in the Journal of the American Medical Association (JAMA) and carried out by researchers from the universities of Bristol, Oxford and Cambridge, involved over 400,000 men aged 50-69. Just under half received a single invitation for a PSA test as part of the trial.
- University of Bristol and UCL to lead support hub for UK's longitudinal population studies 27 March 2024 The University of Bristol and UCL will lead the Population Research UK (PRUK) co-ordination hub, part of an existing strategic investment from the UKRI Infrastructure Fund.
- Patient recovery after surgery for oesophageal cancer isn’t influenced by using standard or keyhole incisions 26 March 2024 New research has found no evidence of a difference between recovery time and complications when comparing standard and keyhole surgical incisions for the treatment of oesophageal cancer (cancer of the gullet). The study, led by the University of Bristol Medical School and published in the British Journal of Surgery, showed surgeons treating patients with oesophageal cancer do not need to change their practice if they have a strong preference for either procedure type.
- New cancer and domestic abuse toolkit launched 26 March 2024 A new toolkit to support cancer professionals to identify and respond to signs of domestic abuse in patients with cancer and their carers is being launched today [26 March]. The toolkit has been developed in partnership with the University of Bristol, Standing Together Against Domestic Abuse, and Macmillan Cancer Support.
- Bristol leaps ahead in training next generation of leaders to tackle major global challenges 12 March 2024 Hundreds of talented scientists and engineers are set to advance solutions for some of the world’s most pressing challenges, ranging from reaching net-zero and developing sustainable energy to improving digital security and making the latest health breakthroughs.
- New Digital Health Hub launches in South West England and Wales 11 March 2024 A consortium of universities from across the South West of England and Wales have come together to form a brand new Digital Health Hub which will elevate the region’s digital health capability through leadership, engagement, acceleration and partnership (LEAP).
- Anti-diabetic drugs could lower risk of primary and secondary brain cancer 22 February 2024 Diabetic patients who take anti-diabetic drugs - known as glitazones – long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found.
- Fakes, facts, society and health 8 February 2024 The Elizabeth Blackwell Institute for Health Research welcomed Patricia Kingori, Professor of Global Health Ethics at the University of Oxford, as their 10th Annual Public Lecture speaker.
Cancer research press releases
Press releases relating to cancer research on the University's central news pages.
Bristol Cancer newsletters
View previous Bristol Cancer newsletters with staff and research news 2015-2023.
Join the Network
Complete our form to join the Bristol Cancer Research Network.